On the recordSeptember 25, 2011
Life science companies must be afforded transparent, predictable, clear regulatory processes to encourage the immense investment that it takes to get a concept from discovery to commercialization.
Source
congress.govEditor's note · Context
Panetta stresses the importance of clear regulations for life science companies.
Share & report
More from Jimmy Panetta
Dec 13, 2023
Madam Speaker, I rise today to recognize and congratulate the new California Division 4-AA football champions, the Soquel High Knights. This is the first team from Santa Cruz County to win a State football title. Head Coach Dwight Lowery…
Dec 5, 2023
This ancient technique may be the solution to solving one of our most modern problems.
May 22, 2024
Now, I was proud to work across the aisle this last December with Congressman Greg Murphy on the Preserving Seniors' Access to Physicians Act, H.R. 6683.
Other voices in this conversation
